Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Study of STP1 in a Subgroup of Patients With Autism Spectrum Disorder (ASD) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating safety, tolerability and pharmacokinetics of STP1 in a subgroup of patients with Autism Spectrum Disorder has completed and results h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• STP1

Snippet

Sponsor: Stalicla SA | Conditions: Autism Spectrum Disorder | Phase 1 | Status: COMPLETED | Results posted: 2024-11-08